Navigation Links
A Genetic Approach For Crohn's And Colitis Disease Is Financed By The Jeffrey Epstein VI Foundation
Date:7/3/2012

NEY YORK, July 3, 2012  /PRNewswire/ -- The Jeffrey Epstein VI Foundation, which actively supports science research, has given substantial support to the Crohn's and Colitis Foundation of America to continue its Genetic Initiative to find a cure for the diseases.

Crohn's is a chronic inflammatory condition of the gastrointestinal tract. Every year, about 700,000 Americans are diagnosed, the majority being between the ages of 15 and 35. Crohn's affects the end of the small bowel, or ileum, the beginning of the colon and parts of the gastrointestinal tract. Ulcerative colitis affects the colon or large intestine.

The cause of Crohn's and Colitis is uncertain but the chronic inflammation stems from the immune system attacking microbial antigens in the gastrointestinal tract. Because of this, the disease is classified as an autoimmune disorder.

What is certain however is that Crohn's has a strong genetic component. Siblings are 30 times more likely to develop Crohn's than the general population. Children of those affected, are 3 to 20 times more likely to develop the disease and twins show a concordance of over 55%.

The Genetic Initiative at the Crohn's and Colitis Foundation of America, which recently received funding from The Jeffrey Epstein VI Foundation, is by far the most comprehensive effort of its kind to isolate the mutated genes that lead to the disease. The Initiative employs a dream team of specialists from different fields to identify genetic mutations and the chain of subsequent pathologies that cause Crohn's and Colitis. The Initiative is headed by Dr. Ramnik Xavier, Chairman of the Department of Gastroenterology at Massachusetts General Hospital in Boston. Xavier's laboratory has identified the largest number of genes associated with Crohn's to date. He is also a founding member of the Center for Computational and Integrative Biology.

The first mutation associated with Crohn's was the NOD2 gene (or CARD15) followed by the discovery of point mutations. Currently, more than thirty genetic mutations have been found, along with their consequences. Mutations of the XBP1 gene for example, directly affect the endoplasmatic reticulum's unfolded protein response pathway. The genetic mutation of ATG16L1 typically induces cell autophagy and can hinder the body's ability to attack invasive bacteria.

"As pluripotent stem cell technology improves, databases like the Genetic Initiative will be invaluable resources to curing such diseases as Crohn's and Colitis," Jeffrey Epstein remarks.

Founded in 1967, the Crohn's and Colitis Foundation of America is a non-profit organization dedicated to finding cures for Crohn's and ulcerative colitis. The Jeffrey Epstein VI Foundation was established in 2000 by science investor and financier, Jeffrey Epstein. Jeffrey Epstein has been an active supporter of genetic research, including the renowned Broad Institute which studies the entire human genome.

 


'/>"/>
SOURCE www.jeffreyepstein.org
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. First Genetic Cure For Cancer Anchors Provocative New Thriller
2. Applied Genetics Initiates Commercial Operation
3. BioRealm to Develop Universal Genetic Screening Tool for Tobacco Addiction and Treatment
4. U.S. Senate Urged to Increase Federal Funding for Research into Hereditary Angioedema, a Rare and Serious Genetic Disorder
5. Study suggests expanding the genetic alphabet may be easier than previously thought
6. Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools
7. JS Genetics announces launch of XCAT-KS, a bloodless, cheek swab test for the diagnosis of Klinefelter syndrome and other Male sex chromosome aneuploidies
8. Global Genetic Engineering Industry
9. Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrigs Disease)
10. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
11. Khan Academy and 23andMe Partner to Promote Genetics Education on DNA Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):